Key result
Subanesthetic ketamine prevents nifedipine-induced developmental cardiotoxicity in zebrafish, whereas acetyl l-carnitine worsens it.
Why the study?
The effects of acetyl l-carnitine on nifedipine toxicity and potential mitigation by ketamine in vivo were unknown.
Does co-treatment with ALCAR or ketamine alter nifedipine-induced developmental toxicity in zebrafish embryos?
Does co-treatment with ALCAR or ketamine alter nifedipine-induced developmental toxicity in zebrafish embryos?
In a zebrafish model, nifedipine toxicity is exacerbated by the dietary supplement ALCAR but alleviated by subanesthetic doses of ketamine.
Answers are grounded in this paper and cite their sources.
Should not alter nifedipine or supplement use in patients; leaves open ketamine protection beyond zebrafish models.
Calcium channel blocker (CCB) poisoning is a common and sometimes life-threatening emergency. Our previous studies have shown that acetyl l-carnitine (ALCAR) prevents cardiotoxicity and developmental toxicity induced by verapamil, a CCB used to treat patients with hypertension. Here, we tested whether toxicities of nifedipine, a dihydropyridine CCB used to treat hypertension, can also be mitigated by co-treatment with ALCAR. In the zebrafish embryos at three different developmental stages, nifedipine induced developmental toxicity with pericardial sac edema in a dose-dependent manner, which were surprisingly exacerbated with ALCAR co-treatment. Even with low-dose nifedipine (5 μm), when the pericardial sac looked normal, ALCAR co-treatment showed pericardial sac edema. We hypothesized that toxicity by nifedipine, a vasodilator, may be prevented by ketamine, a known vasoconstrictor. Nifedipine toxicity in the embryos was effectively prevented by co-treatment with low (subanesthetic) doses (25-100 μm added to the water) of ketamine, although a high dose of ketamine (2 mm added to the water) partially prevented the toxicity.As expected of a CCB, nifedipine either in the presence or absence of ketamine-reduced metabolic reactive oxygen species (ROS), a downstream product of calcium signaling, in the rapidly developing digestive system. However, nifedipine induced ROS in the trunk region that showed significantly stunted growth indicating that the tissues under stress potentially produced pathologic ROS. To the best of our knowledge, these studies for the first time show that nifedipine and the dietary supplement ALCAR together induce adverse effects while providing evidence on the therapeutic efficacy of subanesthetic doses of ketamine against nifedipine toxicity in vivo.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (2019) studied Nifedipine toxicity. Acetyl l-carnitine (ALCAR) or Ketamine vs. Nifedipine alone was evaluated on Developmental toxicity with pericardial sac edema. In zebrafish embryos, nifedipine-induced developmental toxicity was exacerbated by acetyl l-carnitine but effectively prevented by co-treatment with subanesthetic doses of ketamine.
Synapse has enriched 10 related papers. Consider them for comparative context: